Myers S - Search Results

1

Multiple species of canine Rhipicephalus complex detected in Canada.

Myers S, Clow K, DeWinter S, Sundstrom K, Little S. Myers S, et al. Vet Parasitol Reg Stud Reports. 2024 Feb;48:100976. doi: 10.1016/j.vprsr.2023.100976. Epub 2023 Dec 20. Vet Parasitol Reg Stud Reports. 2024. PMID: 38316502 Free article.

2

Dermacentor variabilis (American dog tick).

Myers S, Duncan K. Myers S, et al. Trends Parasitol. 2024 Mar;40(3):273-274. doi: 10.1016/j.pt.2024.01.001. Epub 2024 Jan 22. Trends Parasitol. 2024. PMID: 38262836 No abstract available.

3

Differential regulation of human cathelicidin LL-37 by free fatty acids and their analogs.

Jiang W, Sunkara LT, Zeng X, Deng Z, Myers SM, Zhang G. Jiang W, et al. Peptides. 2013 Dec;50:129-38. doi: 10.1016/j.peptides.2013.10.008. Epub 2013 Oct 18. Peptides. 2013. PMID: 24140860

4

Has the name PCOS run its course?

Myers SH, Forte G, Unfer V. Myers SH, et al. Arch Gynecol Obstet. 2024 Jun 5. doi: 10.1007/s00404-024-07571-6. Online ahead of print. Arch Gynecol Obstet. 2024. PMID: 38836930 No abstract available.

5

Dose dense doxorubicin plus cyclophosphamide in a modified KEYNOTE522 regimen for triple negative breast cancer.

Mai N, Myers S, Shen S, Downs-Canner S, Robson M, Norton L, Chen Y, Traina T, Abuhadra N. Mai N, et al. Among authors: myers s. NPJ Breast Cancer. 2024 Jun 4;10(1):39. doi: 10.1038/s41523-024-00643-5. NPJ Breast Cancer. 2024. PMID: 38834621

6

ASO Visual Abstract: Impact of Neoadjuvant Chemoimmunotherapy on Surgical Outcomes and Time to Radiation in Triple-Negative Breast Cancer.

Myers SP, Sevilimedu V, Jones VM, Abuhadra N, Montagna G, Plitas G, Morrow M, Downs-Canner SM. Myers SP, et al. Ann Surg Oncol. 2024 Jun 4. doi: 10.1245/s10434-024-15491-7. Online ahead of print. Ann Surg Oncol. 2024. PMID: 38833059 No abstract available.

7

In vivo CRISPR screening identifies geranylgeranyl diphosphate as a pancreatic cancer tumor growth dependency.

Kubota CS, Myers SL, Seppälä TT, Burkhart RA, Espenshade PJ. Kubota CS, et al. Among authors: myers sl. Mol Metab. 2024 May 30:101964. doi: 10.1016/j.molmet.2024.101964. Online ahead of print. Mol Metab. 2024. PMID: 38823776 Free article.

8

ASO Author Reflections: Immune-Related Adverse Events During Neoadjuvant Chemoimmunotherapy for Triple-Negative Breast Cancer May Influence Time to Adjuvant Radiation.

Myers SP, Downs-Canner SM. Myers SP, et al. Ann Surg Oncol. 2024 May 22. doi: 10.1245/s10434-024-15445-z. Online ahead of print. Ann Surg Oncol. 2024. PMID: 38776008 No abstract available.

9

Impact of Neoadjuvant Chemoimmunotherapy on Surgical Outcomes and Time to Radiation in Triple-Negative Breast Cancer.

Myers SP, Sevilimedu V, Jones VM, Abuhadra N, Montagna G, Plitas G, Morrow M, Downs-Canner SM. Myers SP, et al. Ann Surg Oncol. 2024 May 20. doi: 10.1245/s10434-024-15359-w. Online ahead of print. Ann Surg Oncol. 2024. PMID: 38767803

10

Distances from ligands as main predictive features for pathogenicity and functional effect of variants in NMDA receptors.

Montanucci L, Brünger T, Bhattarai N, Boßelmann CM, Kim S, Allen JP, Zhang J, Klöckner C, Fariselli P, May P, Lemke JR, Myers SJ, Yuan H, Traynelis SF, Lal D. Montanucci L, et al. Among authors: myers sj. medRxiv [Preprint]. 2024 May 7:2024.05.06.24306939. doi: 10.1101/2024.05.06.24306939. medRxiv. 2024. PMID: 38766179 Free PMC article. Preprint.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,933 results

Search Page